MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
7 tracked managers currently hold MLTX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | Q3 2026 | ADD | $40.8M | 0.0 % | 0.0 % | 3,487,241 | +121,734 |
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | ADD | $23.1M | 0.0 % | 0.0 % | 1,976,338 | +260,989 |
| RENAISSANCE TECHNOLOGIES LLC | Q3 2026 | ADD | $20.1M | 0.0 % | 0.0 % | 1,717,568 | +1,074,300 |
| CITADEL ADVISORS LLC | Q3 2026 | TRIM | $20.0M | 0.0 % | 0.0 % | 1,705,760 | -267,133 |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | ADD | $18.0M | 0.0 % | 0.0 % | 1,534,265 | +898,078 |
| Duquesne Family Office LLC | Q3 2026 | NEW | $5.8M | 0.1 % | — | 494,000 | NEW |
| TUDOR INVESTMENT CORP ET AL | Q3 2026 | TRIM | $533.7K | 0.0 % | 0.0 % | 45,612 | -13,128 |